4th Quarter - Report
BAKER & HOSTETLER LLP for FERRING PHARMACEUTICALS, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report (this page) | Jan 20, 2025 | $60,000 | Replaced |
| 4th Quarter - Amendment | Mar 11, 2026 | $60,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Regulatory and reimbursement policy issues related to federal healthcare programs associated with gene therapy and oncology treatments.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM HIGGINS | — |
| CHRIS JONES | — |
| PETER ROSKAM | — |
| TYLER THOMPSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.